FALL AAFCO REGULATORY UPDATES - BALCHEM CORP

Based on the transcript provided, here is the summary of forward-looking statements and future outlooks.

Note: The speaker, Austin Therrell of AFCO, explicitly stated at the beginning that the session's goal is to "highlight some things maybe we should all be paying attention to as we move into 2027." However, the content is primarily regulatory and operational guidance rather than commercial financial guidance. No financial data (revenue, earnings, margins, capex, etc.) is mentioned.

• Explicit Guidance:

  • None. The transcript contains no financial guidance, earnings forecasts, revenue targets, or capital expenditure plans from the speaker or the organization (AFCO).

• Business-Segment Outlook:

  • Pet Food Label Modernization: The implementation of label changes (nutrition facts box, intended use statement, carbohydrate/fiber listing) is ongoing. As of the current survey, 9 states have adopted changes, with 13 states currently in the rulemaking process. Enforcement discretion for non-compliant products is expected to last through 2030 (a six-year period starting in 2024), though this timeline is linked to the broader label modernization policy which may be extended if issues arise.
  • Raw Pet Food Definitions: A new work group is planned to define "raw" in relation to High-Pressure Processing (HPP). A specific HPP definition is expected to be voted on by the general membership at the mid-year meeting in January (referencing the 2027 meeting cycle).
  • Ingredient Approvals:
    • January 2027 Vote: Pending votes by the general AFCO membership for serine endopeptidase enzyme and grass-derived alkali lignin (previously approved by committees).
    • Spring 2027 Update: Approval of nonanoic acid, hydroxypropyl cellulose, calcium salts of isobutyric acid, 2-methylbutyric acid, chromium DL methionine chelate, chromium propionate (for laying hens/breeders), and a yeast culture modification via the SRIS process.
  • New Programs (Potential 2027 Launch):
    • Voluntary Label Review Program: A pilot program proposed for 2027 to review up to 300 products (capped at 10–12 per company). This may transition to a fee-based system post-pilot.
    • Ingredient Certification Program: A voluntary audit scheme proposed for 2027 to allow firms to use the AFCO seal if ingredients meet AFCO definitions and food safety requirements.
    • Laboratory Certification Program: A voluntary audit scheme proposed for 2027 to certify laboratories participating in proficiency testing for higher competency.

• Market and Competitive Outlook:

  • Regulatory Harmonization: Continued focus on aligning US standards with international bodies (ICCF, Canada, EU) to facilitate cross-border ingredient movement.
  • E-Commerce Challenges: Anticipated increase in difficulty for regulators to monitor and sample products entering the market via e-commerce channels, presenting a structural headwind for enforcement.
  • State Regulatory Capacity: Potential for further strain on state feed programs due to turnover and funding challenges, requiring regulators to manage multiple portfolios (pesticides, soil, human food safety).

• Macro / Industry Outlook:

  • FDA GRAS Rule Finalization: Anticipates a potential final rule from FDA on the proposed mandatory GRAS notification program could be published in 2027, though it could extend beyond. Public comments on the proposed rule are due December 9.
  • Farm Bill & "Innovative Feed Act": Expectation that the Senate Ag Committee's "Farm Bill 2.0" language, which includes the Innovative Feed Act (updating FDA review for technical feed additives), may advance in the upcoming lame-duck session or the new Congress starting in January.
  • PER Act: Monitoring of the "Pet Emergency Response" (PER) Act language in House HR 8646; AFCO views current preemption language as "detrimental" and is actively seeking revisions with partners like NASDA.
  • Animal Health Supplement Bill: Anticipation that the National Animal Supplement Council (NASC) will likely introduce a new bill in 2027 (post-new Congress) to create a legal category for animal health supplements.
  • FDA Reorganization: The "Simple Reform" split of CVM into the Office of Veterinary Product Surveillance and Compliance and the Office of Animal Foods is active; no new hires are guaranteed, but rebuilding of reviewer staff is noted as a priority.

• Strategic Initiatives:

  • AFCO Official Publication (2027 Edition): Will include new ingredient definitions (zinc L-selenomethionine, synthetic sodium alumina silicate, etc.) and the new footnote limiting soluble phosphorus (<1g/1000 kcal ME).
  • International Expansion: AFCO is actively seeking to expand international government membership beyond North/South America (currently has Costa Rica and Canada) to increase global influence.
  • Training & Education: Plans to roll out on-demand pet food labeling workshop materials in 2027 and offer an in-person pet food labeling workshop at the January 2027 annual meeting in Orlando.
  • Collagen Definition: Acknowledged as a potential future topic; no current review process exists, but a sponsor would be required to initiate data submission.
  • Senior Dog Nutrient Profiles: Work is ongoing, but currently no profile is expected as published research is deemed insufficient.

• Risks and Headwinds to Outlook:

  • FDA GRAS Rule: The shift from voluntary to mandatory notification could increase documentation burdens; failure to notify could lead to enforcement scrutiny.
  • Label Modernization Timeline: The 2030 enforcement discretion window is contingent on the 2024 label modernization policy; if the latter is extended, the decoupling of timelines may occur.
  • PER Act Preemption: If the current House version of the PER Act passes, its broad preemption clause could void state authority over labeling and marketing, shifting the burden to an understaffed FDA.
  • Innovation Lag: Rapid technological advancement (AI, genomics) and e-commerce distribution are creating a gap where regulators cannot keep pace with new product introductions.
  • Funding/Staffing: Continued risks of state program funding cuts and staff turnover affecting regulatory capacity.

• Management Tone on the Future:

  • Cautiously Optimistic regarding Industry Collaboration: Expresses enthusiasm for the potential of the label review and certification programs, viewing them as "exciting" opportunities to add value.
  • Concern regarding Regulatory Speed: Acknowledges the "speed at which a glacier moves" for government rulemaking but highlights the industry's rapid pace (e-commerce, tech) as a challenge for enforcement.
  • Transparency Focus: Notes FDA's move to a "Policy and Procedures Manual" and transparent timelines as positive steps to reduce uncertainty for submitters.
  • Confidence in Harmonization: Reaffirms the core mission of harmonizing state laws remains unchanged, with a proactive stance on international collaboration.

• Miscellaneous:

  • Meeting Schedule: AFCO Annual/Mid-Year meeting scheduled for January in Orlando (described as a "mid-year meeting" for the 2027 cycle).
  • Comment Deadline: FDA GRAS rule comments due December 9; AFCO plans to release its position comments by "beginning of next week" relative to the transcript date.
  • Future Webinars: Upcoming Balchem Real Science Lectures scheduled for November 24 (lactation lifespans), December 1 (methane emissions), and December 8 (US pet food economic landscape).